Status:
COMPLETED
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
Lead Sponsor:
LMC Diabetes & Endocrinology Ltd.
Conditions:
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to assess foot complications among patients with diabetes in Canada, using patient data collected during diabetes foot assessments performed by the LMC Chiropody Team between February 2...
Detailed Description
Among patients with diabetes, one of the major causes of increased morbidity and mortality include lower-extremity complications. Patients who have peripheral neuropathy and peripheral arterial diseas...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of type 1 or type 2 diabetes
- Under the care of an endocrinologist at LMC
- Diabetes foot assessment was performed by the LMC Chiropody Team
- Informed consent to use patient medical record data for research purposes was provided
Exclusion
- Prior diabetes foot assessment by an LMC chiropodist
Key Trial Info
Start Date :
March 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
5084 Patients enrolled
Trial Details
Trial ID
NCT04327622
Start Date
March 3 2020
End Date
June 30 2020
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LMC Healthcare
Toronto, Canada